These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 35677885)
1. A qPCR-Based Method for Quantification of RCA Contaminants in Oncolytic Adenovirus Products. Gao M; Yngve E; Yu D; Jin C Front Mol Biosci; 2022; 9():883249. PubMed ID: 35677885 [TBL] [Abstract][Full Text] [Related]
2. A qPCR-Based Method for Quantification of Replication Competent Adenovirus (RCA) in Conditionally Replicating Oncolytic Adenoviruses. Yngve E; Gao M; Yu D Methods Mol Biol; 2022; 2521():249-258. PubMed ID: 35733002 [TBL] [Abstract][Full Text] [Related]
3. Adenoviral Gene Therapy Vectors in Clinical Use-Basic Aspects with a Special Reference to Replication-Competent Adenovirus Formation and Its Impact on Clinical Safety. Leikas AJ; Ylä-Herttuala S; Hartikainen JEK Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003709 [TBL] [Abstract][Full Text] [Related]
4. Detection of replication-competent adenoviruses spiked into recombinant adenovirus vector products by infectivity PCR. Ishii-Watabe A; Uchida E; Iwata A; Nagata R; Satoh K; Fan K; Murata M; Mizuguchi H; Kawasaki N; Kawanishi T; Yamaguchi T; Hayakawa T Mol Ther; 2003 Dec; 8(6):1009-16. PubMed ID: 14664804 [TBL] [Abstract][Full Text] [Related]
5. Characterization of replication-competent adenovirus isolates from large-scale production of a recombinant adenoviral vector. Zhu J; Grace M; Casale J; Chang AT; Musco ML; Bordens R; Greenberg R; Schaefer E; Indelicato SR Hum Gene Ther; 1999 Jan; 10(1):113-21. PubMed ID: 10022536 [TBL] [Abstract][Full Text] [Related]
6. A replication-competent adenovirus assay for E1-deleted Ad35 vectors produced in PER.C6 cells. Marzio G; Kerkvliet E; Bogaards JA; Koelewijn S; De Groot A; Gijsbers L; Weverling GJ; Vogels R; Havenga M; Custers J; Pau MG; Guichoux JY; Lewis J; Goudsmit J Vaccine; 2007 Mar; 25(12):2228-37. PubMed ID: 17250936 [TBL] [Abstract][Full Text] [Related]
7. Oncolytic E1B 55KDa-deleted adenovirus replication is independent of p53 levels in cancer cells. Abbas BM; El-Mogy MA; Haj-Ahmad Y Cell Mol Biol (Noisy-le-grand); 2017 Aug; 63(7):1-11. PubMed ID: 28838332 [TBL] [Abstract][Full Text] [Related]
8. A New HEK293 Cell with CR2 Region of E1A Gene Deletion Prevents the Emergence of Replication-Competent Adenovirus. Lian X; Zhao X; Zhong J; Zhang C; Chu Y; Wang Y; Lu S; Wang Z Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136259 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of E1B gene-attenuated replicating adenoviruses for cancer gene therapy. Kim J; Cho JY; Kim JH; Jung KC; Yun CO Cancer Gene Ther; 2002 Sep; 9(9):725-36. PubMed ID: 12189522 [TBL] [Abstract][Full Text] [Related]
10. Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus. Liu TC; Wang Y; Hallden G; Brooks G; Francis J; Lemoine NR; Kirn D Gene Ther; 2005 Sep; 12(17):1333-46. PubMed ID: 15920462 [TBL] [Abstract][Full Text] [Related]
11. Replication-competent adenovirus formation in 293 cells: the recombination-based rate is influenced by structure and location of the transgene cassette and not increased by overproduction of HsRad51, Rad51-interacting, or E2F family proteins. Duigou GJ; Young CS J Virol; 2005 May; 79(9):5437-44. PubMed ID: 15827158 [TBL] [Abstract][Full Text] [Related]
12. A simple method for the simultaneous detection of E1A and E1B in adenovirus stocks. Suzuki E; Murata T; Watanabe S; Kujime Y; Hirose M; Pan J; Yamazaki T; Ugai H; Yokoyama KK Oncol Rep; 2004 Jan; 11(1):173-8. PubMed ID: 14654922 [TBL] [Abstract][Full Text] [Related]
13. Development of a recombinant adenovirus vector production system free of replication-competent adenovirus by utilizing a packaging size limit of the viral genome. Suzuki T; Sasaki T; Yano K; Sakurai F; Kawabata K; Kondoh M; Hayakawa T; Yagi K; Mizuguchi H Virus Res; 2011 Jun; 158(1-2):154-60. PubMed ID: 21470569 [TBL] [Abstract][Full Text] [Related]
14. Markedly enhanced cytolysis by E1B-19kD-deleted oncolytic adenovirus in combination with cisplatin. Yoon AR; Kim JH; Lee YS; Kim H; Yoo JY; Sohn JH; Park BW; Yun CO Hum Gene Ther; 2006 Apr; 17(4):379-90. PubMed ID: 16610926 [TBL] [Abstract][Full Text] [Related]
18. Detection Assay for Replication-Competent Adenovirus by Concentration Passage and Real-Time Quantitative Polymerase Chain Reaction (qPCR). Lock M; Alvira M; Wilson J; Sena-Esteves M; Gao G Cold Spring Harb Protoc; 2019 Dec; 2019(12):. PubMed ID: 31792138 [TBL] [Abstract][Full Text] [Related]
19. Replicating adenoviruses in cancer therapy. Dobbelstein M Curr Top Microbiol Immunol; 2004; 273():291-334. PubMed ID: 14674605 [TBL] [Abstract][Full Text] [Related]
20. A new complementing cell line for replication-incompetent E1-deleted adenovirus propagation. Xu Q; Arevalo MT; Pichichero ME; Zeng M Cytotechnology; 2006 Jul; 51(3):133-40. PubMed ID: 19002883 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]